Interleukin 4 Receptor alpha Antagonists [MoA] - N0000193341

Pharmacologic Code	N0000193341
Pharmacologic Name	Interleukin 4 Receptor alpha Antagonists
Pharmacologic Uses	interleukin-4 receptor alpha antagonist
Pharmacologic Concept	Mechanisms of Action - [MoA]
Pharmacologic Concept Description	This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

The table contains 5 products whose active ingredient are classified under the same pharmacologic class Interleukin 4 Receptor alpha Antagonists [MoA].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	0024-5911	Dupixent	Non-Proprietary Name: Dupilumab	Injection, Solution	Subcutaneous	Sanofi-aventis U.s. Llc	ACTIVE
	0024-5914	Dupixent	Non-Proprietary Name: Dupilumab	Injection, Solution	Subcutaneous	Sanofi-aventis U.s. Llc	ACTIVE
	0024-5915	Dupixent	Non-Proprietary Name: Dupilumab	Injection, Solution	Subcutaneous	Sanofi-aventis U.s. Llc	ACTIVE
	0024-5918	Dupixent	Non-Proprietary Name: Dupilumab	Injection, Solution	Subcutaneous	Sanofi-aventis U.s. Llc	ACTIVE
	0024-5919	Dupixent	Non-Proprietary Name: Dupilumab	Injection, Solution	Subcutaneous	Sanofi-aventis U.s. Llc	ACTIVE